BioLife Solutions (BLFS) Tops Q1 EPS by 13c, Beats on Revenue
Tweet
Share
E-mailGet Alerts BLFS Hot Sheet
Price: $35.16 +0.54%
Financial Fact:
Cost of product sales: 920.94K
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Cost of product sales: 920.94K
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
BioLife Solutions (NASDAQ: BLFS) reported Q1 EPS of ($0.22), $0.13 better than the analyst estimate of ($0.35). Revenue for the quarter came in at $31.73 million versus the consensus estimate of $27.42 million.
For earnings history and earnings-related data on BioLife Solutions (BLFS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jefferies sees a buying opportunity in this S&P 500 sector
- Ideal Power (IPWR) Tops Q2 EPS by 2c
- Activist investors push Seer, Inc. to disclose go-private timeline
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
